维普中文期刊产品整合服务
6篇 您的检索式:作者名="Mujakovic"
    题名 作者 年代 出处 被引量
1Non-homogeneous boundary value problem for one-dimensional compressible viscous mi- cropolar fluid model: a global existence theory显示文摘MUJAKOVIC N 2009Mathematical Inequalities and Applications2009,12,:1
2GLOBAL SOLUTION TO 1D MODEL OF A COMPRESSIBLE VISCOUS MICROPOLAR HEAT-CONDUCTING FLUID WITH A FREE BOUNDARY显示文摘In this paper we consider the nonstationary 1D flow of the compressible viscous and heat-conducting micropolar fluid,assuming that it is in the thermodynamically sense perfect and polytropic.The fluid is between a static solid wall and a free boundary connected to a vacuum state.We take the homogeneous boundary conditions for velocity,microrotation and heat flux on the solid border and that the normal stress,heat flux and microrotation are equal to zero on the free boundary.The proof of the global existence of the solution is based on a limit procedure.We define the finite difference approximate equations system and construct the sequence of approximate solutions that converges to the solution of our problem globally in time.Nerming MUJAKOVIC Nelida CRNJARIC-ZIC 2016Acta Mathematica Scientia2016,36,6:1
3Psychopathology is associated with dyspeptic symptom severity in primary care patients with a new episode of dyspepsia显示文摘Mujakovic S de Wit N J van Marrewijk C J 0,,:1
41D compressible viscous micropolar fluid model with non-homogeneous boundary condi- tions for temperature a local existence theorem显示文摘MUJAKOVIC N 2012Nonlinear Analysis: Real world Applications2012,13,:1
5Effect and cost - effectiveness of step - up versus step - down treatment with antacids,H2 -receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study):a primary - care - based randomised controlled trial 显示文摘van Marrewijk C J Mujakovic S Fransen GA 2009Lancet2009,373,:1
6应用抑酸剂、H2受体拮抗剂和质子泵抑制剂升序或降序治疗新发消化不良的效果与成本效益分析(DIAMOND研究):一项基于初级保健的随机对照试验显示文摘背景在消化不良的初级保健中,医生的大量工作负担和高额的医疗费用均与治疗密切相关。尽管有关共识和指南已经形成,但该病最经济的初始治疗策略仍未明确。本研究对初级卫生保健中新发消化不良的升序与降序治疗作一比较。方法在新西兰年龄≥18、因新发消化不良就诊于家庭医生的患者均可纳入这项双盲、随机对照试验。2003年10月-2006年1月,采用计算机生成的序列(区块数为6),随机分配664例患者接受抑酸剂、H,受体拮抗剂、质子泵抑制荆升序(n=341)或降序(n=323)阶梯治疗。每阶段持续4周,只有在4周内症状持续或复发时,才能进入下一阶段。主要结局为6个月时症状缓解的情况以及初始治疗的成本效益。采用意向性治疗(ITT)分析,ITT人群包括所有在6个月时获得主要结局数据的患者。本试验已在ClinicalTrials.gov注册.注册号为NCT00247715。结果升序组332例、降序组313例达到观察终点,并获得了充分的评估数据;退出试验的主要原因是失访。治疗6个月后,升序组238例(72%)和降序组219例(70%)治疗获得成功(OR0.92,95%C10.7~1-3)。升序组的平均医疗费用低于降序组(E228 vs ∈245;P=0.0008),这主要是由于药物费用不同所致。升序组94例(28%)、降序组93例(29%)报告≥1次药物相关不良事件,但均不严重,包括消化不良症状、腹泻、便秘、口干/口苦等。结论在新发消化不良的初级保健中,尽管升序治疗与降序治疗的成功率相似,但在6个月时升序治疗策略显得更为经济划算。Corine J van Marrewijk Suhreta Mujakovic Gerdine A J Fransen Mattijs E Numans Niek J de Wit Jean W M Muris martijn G H van Oijen Jan B M J Jansen Diederik E Grobbee J Andre Knottnenus RobertJ F Laheij 2009世界临床医学2009,,7:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费